Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers

Collegium Pharmaceutical Inc. (NASDAQ:COLL) is 1 of the 7 champion small-cap cause manufacturing stocks to bargain according to hedge funds.

On March 24, Vikram Karnani, President and CEO astatine Collegium Pharmaceutical Inc. (NASDAQ:COLL), shared his views connected the company’s caller statement with Corium Therapeutics Holdings for the acquisition of AZSTARYS. The woody involves $650 cardinal successful currency payments, on with earn-out considerations that could scope $135 million.

pikselstock/Shutterstock.com

Karnani emphasized that this transaction volition alteration the institution to further diversify its topline, beyond the symptom medicines category. He besides highlighted that it volition proceed to lend to the company’s gross basal done to the precocious 2030s, further strengthening Collegium’s beingness wrong the ADHD space. Given the company’s existing operational and selling capabilities wrong ADHD, this summation volition pb to expanded margins and higher operating leverage.

On February 23, Boston Legacy FC named Collegium Pharmaceutical Inc. (NASDAQ:COLL) an authoritative spouse and announced a multi-year concern with the company. Boston Legacy FC and Collegium are collaborating to marque the club’s location games much comfy and inclusive for fans.

Under this partnership, the Collegium Sensory Room astatine Gillette, Centreville, and White Stadium volition beryllium made disposable for each Boston Legacy FC location matches successful 2027. The sensory country is simply a circumstantial country designed to springiness fans and visitors a much peaceful and safer situation distant from the aggravated ocular and acoustic aspects experienced during the match, frankincense enhancing the acquisition of the visitors and making it much pleasurable and comfortable.

Collegium Pharmaceutical Inc. (NASDAQ:COLL) focuses connected the improvement and commercialization of symptom absorption medicines. It offers a wide scope of products, which see Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR, and Symproic.

While we admit the imaginable of COLL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.